Location: Philadelphia
Synced from ClinicalTrials.gov · July 28, 2026
Clinical studies recruiting near Philadelphia
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
Phase 3 · Investigative Site US056 · Incyte Corporation · NCT06959225Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the
NA · Temple University Hospital · Fisher and Paykel Healthcare · NCT07222410To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
Phase 3 · Biomed Testing Facility #BIO-17-19104 · Biomed Industries, Inc. · NCT06840496The PREDICT Registry:
Phase N/A · Sidney Kimmel Comprehensive Cancer Ctr - Jefferson · PreludeDx · NCT03448926Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Phase 1 · University of Pennsylvania · USWM CT, LLC · NCT03391778Cigarillo Public Education Messaging for Black Young Adults
NA · Drexel University · Drexel University · NCT06863168First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia
Phase 1 · Children's Hospital of Philadelphia · Allterum Therapeutics, Inc · NCT07586618Product Surveillance Registry
Phase N/A · Medtronic · NCT01524276A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Phase 3 · Children's Hosptl Philadelphia · Novo Nordisk A/S · NCT06612268Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Phase 2 · Temple University · Johns Hopkins University · NCT07059091Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplant
Phase 2 · Abramson Cancer Center of the University of Pennsylvania Med · New York Blood Center · NCT01656603Self-Management for Head and Neck Lymphedema and Fibrosis [PROMISE Trial]
NA · University of Pennsylvania · Abramson Cancer Center at Penn Medicine · NCT06125743Neoadjuvant Darovasertib in Primary Uveal Melanoma
Phase 3 · Jefferson Health Honickman Center · IDEAYA Biosciences · NCT07015190Topical Anti-Androgens in Pilonidal Sinus Disease
Phase 2 · University of Pennsylvania · University of Pennsylvania · NCT06286397Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
Phase N/A · The Children's Hospital of Philadelphia · Children's Hospital of Philadelphia · NCT06389994Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Phase 2 · Children's Hospital of Philadelphia - Main /ID# 234313 · AbbVie · NCT03339128A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
Phase 1 · Children's Hospital of Philadelphia (CHOP) ( Site 0003) · Merck Sharp & Dohme LLC · NCT07199465Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marr
Phase 1/Phase 2 · Hospital of the University of Pennsylvania · National Cancer Institute (NCI) · NCT04959175A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard
Phase N/A · The Children's Hospital of Philadelphia · Regeneron Pharmaceuticals · NCT06693531Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Phase N/A · The Children's Hospital of Philadelphia · Jaeb Center for Health Research · NCT06837181ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
NA · Lankenau Institute for Medical Research · JenaValve Technology, Inc. · NCT06608823A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 2 · Thomas Jefferson University, Sidney Kimmel Comprensive Cance · BicycleTx Limited · NCT07450859Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · University of Pennsylvania/Abramson Cancer Center · National Cancer Institute (NCI) · NCT05987241Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
Phase 2/Phase 3 · Children's Hospital of Philadelphia · Yale University · NCT04924322Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · University of Pennsylvania Abramson Cancer Center · Gilead Sciences · NCT05633654A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and N
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06256588Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumo
Phase 1/Phase 2 · Children's Hospital of Philadelphia (CHOP) ( Site 1021) · Merck Sharp & Dohme LLC · NCT06395103Orphan Indications for CD19 Redirected Autologous T Cells
Phase 2 · Children's Hospital of Philadelphia · Stephan Grupp MD PhD · NCT04276870MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Penn Presbyterian Med Ctr · Stryker Instruments · NCT03072927VIBRANT: VIB4920 for Active Lupus Nephritis
Phase 2 · Temple University, Lewis Katz School of Medicine, Department · National Institute of Allergy and Infectious Diseases (NIAID · NCT05201469
Look up another city
Look up another condition